Business Wire

NY-UPTIME-INSTITUTE

20.9.2022 12:03:37 CEST | Business Wire | Press release

Share
Uptime Institute’s 2022 Global Data Center Survey Reveals Strong Industry Growth as Operators Brace for Expanding Sustainability Requirements

Uptime Institute today announced the release of its 12th Annual Global Data Center Survey. The findings show an industry that is growing, dynamic and increasingly resilient, but still working to address increasing pressure for sustainability progress and reporting, continuing staffing shortages, supply chain delays, costly outages and other complex challenges.

“The global digital infrastructure sector continues to enjoy strong growth and expansion, despite the many obstacles operators are facing today,” said Andy Lawrence, executive director of research, Uptime Institute Intelligence. “We’ve seen the industry invest in increased resiliency and reliability, but there’s still work to be done when it comes to improving efficiency, environmental sustainability, outage prevention, staffing pipelines and more.”

Uptime’s annual Global Data Center Survey is the largest and most comprehensive in the digital infrastructure industry. It provides detailed insights into the digital critical infrastructure landscape and a sense of its future trajectory. Key findings from the 2022 report include:

  • Many data center operators are unprepared for mounting sustainability requirements and regulations – Most respondents say they report on overall data center power use and PUE, but many still are not tracking critical environmental metrics. Although 63% of operators believe authorities in their region will require them to publicly report environmental data in the next five years, just 37% collect and report carbon emissions data (a slight increase over 33% in 2021) and only 39% currently report their water use (a 12% drop compared to 2021). New laws, standards, and requirements will force operators to address these gaps and establish more stringent sustainability tracking and reporting practices in the coming years.
  • PUE progress is in stasis for now and future efficiency gains must focus on IT power – The average annual power usage effectiveness (PUE) reported in 2022 was 1.55. This represents a slight improvement over the 2021 average of 1.57, which is consistent with the trend of marginal PUE gains Uptime has observed annually since 2014. Going forward, achieving substantial data center efficiency improvements will require a new focus on IT efficiency, along with metrics to track and report progress.
  • More operators are investing to bolster data center resiliency – Data center owners and operators are making significant investments in the resiliency of their physical infrastructure, with about 40% of respondents reporting increased redundancy levels at their primary data centers in the past three to five years. Power and cooling systems have received similar attention, with a third of operators upgrading either or both.
  • Outages are becoming more expensive and are still far too frequent – The share of all outages costing operators over $1 million has reached 25%, a significant increase from 15% in 2021. In 2022, 60% of operators reported experiencing an outage (regardless of severity) in the past three years — down from 69% in 2021 and 78% in 2020. Although the data indicates a trend toward improved outage rates, the frequency of outages is still much too high and with more than two-thirds now costing operators upwards of $100,000, the consequences are getting worse.
  • Operators’ confidence in public cloud is on the rise, despite ongoing outage risks – As the perception of improved visibility into cloud operational resiliency grows, organizations are more likely to trust the cloud for mission-critical workloads. In 2022, just 63% of operators are not placing mission-critical workloads into a public cloud, a substantial drop from almost 75% in 2019. That trust might be misplaced, given that more than one-third of respondents report that public cloud availability zone outages (which are relativity common) would cause significant performance issues.
  • Data center equipment vendors optimistic despite demand pressures and lingering supply chain problems – Three-quarters of vendors project year-over-year revenue growth in 2022 despite reporting dampened revenues due to persistent COVID-induced supply chain issues. Nearly half of respondents involved with data center construction have suffered significant delays (or other events) in their supply chains, while one-third have experienced moderate issues.
  • Problems attracting and retaining qualified staff are worsening – Over half (53%) of data center operators report difficulty finding qualified employees in 2022 — up from 47% in 2021 and 38% in 2018. And 42% of respondents report issues with staff being hired away (in most cases to data center competitors) – a massive increase over just 17% in 2018, which demonstrates the growing challenge of employee retention throughout the sector.

Learn More: Uptime’s 2022 Global Data Center Survey also includes findings on industry attitudes toward nuclear energy, server refresh rates, rack density trends and much more. Download the complete report here, and register for the webinar covering its key trends and takeaways on September 28th at 11:00 a.m. ET.

About the Survey: Uptime conducts its annual Global Data Center Survey online and by email. This year’s study took place in H1 2022, and includes responses from approximately 800 data center owners and operators responsible for managing infrastructure at the world’s largest IT organizations. It also includes insights from 700 data center suppliers, designers, and advisors worldwide.

About Uptime Institute

Uptime Institute is the Global Digital Infrastructure Authority. For over 25 years, the company has established industry-leading benchmarks for data center performance, resilience, sustainability, and efficiency, which provide customers assurance that their digital infrastructure can perform across a wide array of operating conditions at a level consistent with their business needs. Uptime’s Tier Standard is the IT industry’s most trusted and adopted global standard for the design, construction, and operation of data centers – the backbone of the digital economy. With its Tier Standard and Certifications, Management & Operations reviews, SCIRA-FSI financial sector risk assessment, broad range of additional risk and performance assessments, Intelligence research services, and accredited training courses completed by over 10,000 data center professionals, Uptime has helped thousands of companies in over 100 countries to optimize critical IT assets while managing costs, resources, and efficiency.

Uptime Institute is headquartered in New York, NY, with offices in Seattle, London, Sao Paulo, Dubai, Singapore, and Taipei. For more information, please visit www.uptimeinstitute.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220920005231/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye